Braveheart Bio Surges in Market Debut After Up-sized $382.5M

Braveheart Bio made a strong Wall Street debut Thursday, with shares soaring more than 70% after the clinical-stage cardiovascular drug developer... Read More
The post Braveheart Bio Surges in Market Debut After Up-sized $382.5M appeared first on citybiz.
